SAN FRANCISCO--(BUSINESS WIRE)--Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP - News) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, Cholera and malaria detection, and other innovative technologies, today announced CEO Clayton Hardman attended a series of meetings on the important topic of diagnosing and managing tuberculosis (“TB”) with industry leaders from the Centers for Disease Control, the Foundation for New Innovative Diagnostics (“FIND”), the World Health Organization and the University of KwaZulu-Natal, South Africa and others, at a Symposium hosted by Los Alamos National Laboratory.
